The rising interest in GLP-1 agonists for diabetes has led to a discussion about delivery routes : transdermal systems versus tablets . Usually , GLP-1 treatments were only available in pill form, but https://lilliaaos906895.affiliatblogger.com/93352063/glp-1-skin-applications-vs-tablets-is-best-for-individuals